ILTS Insights: Current status and timing of pediatric liver transplantation

Experts Manuel Rodriguez-Davalos and Nam-Joon Yi share their insights in this first of two webinars organized by the ILTS Pediatrics Commitee.

November 3, 2021
Overview

Webinar

ILTS Insights: Current status and timing of pediatric liver transplantation

 

The ILTS Pediatrics Committee invites you to join two webinars in November 2021!

 

In this first webinar, Manuel Rodriguez-Davalos will present the Global Census of Pediatric Liver Transplantation, for which the ILTS Pediatrics Committee surveyed 108 pediatric liver transplant programs from 36 countries across all continents regarding their liver transplantation practices. Nam Joon Yi will share her insights on the timing of pediatric liver transplantation for biliary atresia and metabolic liver disease.

 

Objectives:

  • Review current outcomes of liver transplantation in children in the world
  • Discuss the indication and surgical technique of liver transplantation for biliary atresia

Agenda:

  • Introduction
  • Global Census of Pediatric Liver Transplantation (Manuel Rodriguez-Davalos)
  • Liver Transplantation for Biliary Atresia (Nam-Joon Yi)
  • Q&A moderated by Ciğdem Arıkan and Mureo Kasahara

 

Speakers

Manuel Rodriguez-Davalos, MD, Medical Director, Living Donor Liver Transplantation Program, Intermountain Medical Center and Surgical Director, Pediatric Liver Transplantation, Primary Children’s Hospital, Intermountain Healthcare. Dr. Rodriguez-Davalos has previously held positions in transplant at Yale University, Mount Sinai Medical Center and New York Medical College.He is committed to innovation and collaboration to improve organ donation, transplantation and allocation systems to benefit those in need, especially children.

He has particular interest in living donor transplants, organ allocation, and portal hypertension. His current research involves living donor liver transplantation, the use of partial grafts and extended criteria for donation in liver transplantation, and preservation techniques for decreasing ischemia-reperfusion injury.

He has served on numerous liver transplantation advisory boards and was a member at large of the United Network for Organ Sharing (UNOS) Liver Committee and as well as the pediatric transplantation committee. He is part of the publications committee with IPTA, Education committee of TTS, Associate editor of our journal “Transplantation”, Task force for liver allocation with SPLIT and oversees the International Liver Transplant Society Pediatric Liver Transplant Registry.

He received his medical degree from the Anahuac University. He did a year of research in portal hypertension and hepatobiliary surgery at the National Institutes of Health System in Mexico. He was a surgical intern at the Mayo Clinic in Rochester, MN, and completed his surgical training at the Mayo Clinic Hospital in Scottsdale, AZ. He was a clinical fellow in multi-organ transplant surgery at Mount Sinai Medical Center.

Nam-Joon Yi, MD, PhD, is currently a professor of Surgery at Seoul National University College of Medicine. She obtained her MD and PhD degrees at the Ewha Womans University in Seoul, Korea, in 1996 and 2004. Since 2002, she started her clinical fellowship and has been dedicated to setting up a living donor liver transplantation program in the HBP Surgery division of Seoul National University Hospital. She has special expertise in living donor and pediatric liver transplantation. Her research interests include microchimerism of the liver graft in the pediatric transplantation, regeneration of the small for size graft, and operational tolerance in liver transplantation.

 

Moderators

Ciğdem Arıkan, MD, completed her high school education in Istanbul Erenkoy High school in 1995 and then graduated from İstanbul University Medical Faculty. She got her degree on children’s health and diseases in Marmara University İn the year 2001, the same year in Ege University she started Child Gastroenterology, Hepatology and nutrition science as a side branch and graduated in the year 2005. Between the years 2005-2006 she worked in the Texas Childrens Hospital Liver research center. Dr. Arıkan won 6 scientific awards, 2 abroad research scholarships, 62 international research articles and Her h-index is 22. She is a member of ILTS, ESPGHAN, EASL, IPTRA, the Turkish Liver research association, the Turkish Pediatric Association, the Turkish Pediatric Gastroenterology, Hepatology and Nutrition Association, KEPAN and works as an advisor for many international magazines.

Mureo Kasahara, MD, PhD, started his professional career in HPB and transplant surgery at Kyoto University School of Medicine starting in 1996. He also served as a fellow at the Liver Transplant Surgery Service in King’s College Hospital in London, UK, in 2002. Dr. Kasahara is now the Head of Transplant Center, Vice Chairman in the internationally renowned National Center for Child Health and Development in Tokyo, Japan. Since 1996, he has performed the largest number of living-related pediatric liver transplants (1600 cases) on children from all over the world. Several firsts have been achieved under his supervision in 2020 at National Center for Child Health and Development, first in human clinical study of regenerative medicine, and ES cell-driven hepatocyte transplantation for congenital metabolic liver disease.

 

This Webinar is Supported by Bridge to Life

ILTS would like to thank Bridge to Life for their generous support for the production of this webinar. Bridge to Life has had no influence on the content, and full editorial control remains the sole responsibility of ILTS.

 

Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, Bridge to Life continues to explore emerging science and preservation technologies.

https://bridgetolife.eu

More from this meeting
More from these speakers